Escape from treatment; the different faces of leukemic stem cells and therapy resistance in acute myeloid leukemia

N Van Gils, F Denkers, L Smit - Frontiers in oncology, 2021 - frontiersin.org
Standard induction chemotherapy, consisting of an anthracycline and cytarabine, has been
the first-line therapy for many years to treat acute myeloid leukemia (AML). Although this …

[HTML][HTML] Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities

E O'Reilly, HA Zeinabad, E Szegezdi - Blood Reviews, 2021 - Elsevier
Hematopoietic stem cells (HSC) are responsible for the production of mature blood cells. To
ensure that the HSC pool does not get exhausted over the lifetime of an individual, most …

A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex–mediated DNA replication

Y Sheng, J Wei, F Yu, H Xu, C Yu, Q Wu… - Blood, The Journal …, 2021 - ashpublications.org
YTHDC1 has distinct functions as a nuclear N 6-methyladenosine (m6A) reader in
regulating RNA metabolism. Here we show that YTHDC1 is overexpressed in acute myeloid …

Drug resistance mechanisms of acute myeloid leukemia stem cells

J Niu, D Peng, L Liu - Frontiers in Oncology, 2022 - frontiersin.org
Acute myeloid leukemia (AML) is a polyclonal and heterogeneous hematological
malignancy. Relapse and refractory after induction chemotherapy are still challenges for …

A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411

Z Khademi, M Ramezani, M Alibolandi, MR Zirak… - Carbohydrate …, 2022 - Elsevier
A facile method was designed that can specifically deliver CRISPR/Cas9 into target cells
nuclei and reduce the off-target effects. A multifunctional delivery vector for FOXM1 knockout …

A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability

J Wang, F Shao, Y Yang, W Wang… - Cancer …, 2022 - Wiley Online Library
Background Maintenance of cancer stem‐like cell (CSC) stemness supported by aberrantly
regulated cancer cell metabolism is critical for CSC self‐renewal and tumor progression. As …

MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3

W Liu, D Shen, L Ju, R Zhang, W Du, W Jin, K Xiong… - Oncogene, 2022 - nature.com
The transcription factor MYB proto-oncogene like 2 (MYBL2) is critical in regulating gene
expression and tumorigenesis. However, the biological function of MYBL2 in bladder cancer …

Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth

SG Kellaway, S Potluri, P Keane, HJ Blair… - Nature …, 2024 - nature.com
Abstract Acute Myeloid Leukemia (AML) is caused by multiple mutations which dysregulate
growth and differentiation of myeloid cells. Cells adopt different gene regulatory networks …

Transcription factor–nucleosome dynamics from plasma cfDNA identifies ER-driven states in breast cancer

S Rao, AL Han, A Zukowski, E Kopin, CA Sartorius… - Science …, 2022 - science.org
Genome-wide binding profiles of estrogen receptor (ER) and FOXA1 reflect cancer state in
ER+ breast cancer. However, routine profiling of tumor transcription factor (TF) binding is …

Small-molecule inhibitors targeting FOXM1: current challenges and future perspectives in cancer treatments

S Raghuwanshi, AL Gartel - Biochimica et Biophysica Acta (BBA)-Reviews …, 2023 - Elsevier
Forkhead box (FOX) protein M1 (FOXM1) is a critical proliferation-associated transcription
factor (TF) that is aberrantly overexpressed in the majority of human cancers and has also …